Leslie Heisz Biography and Net Worth

Leslie Stone Heisz serves as Independent Director of the Company. Ms. Heisz’s career in the banking industry, in-depth knowledge of capital markets, and previous public company board and audit committee experience enhances our Board’s ability to effectively oversee financial reporting, enterprise and operational risk management, as well as corporate finance, tax, treasury, and governance matters.

What is Leslie S. Heisz's net worth?: The estimated net worth of Leslie S. Heisz is at least $2.37 million as of February 8th, 2024. Ms. Heisz owns 26,980 shares of Edwards Lifesciences stock worth more than $2,366,955 as of April 24th. This net worth evaluation does not reflect any other investments that Ms. Heisz may own. Learn More about Leslie S. Heisz's net worth.
How do I contact Leslie S. Heisz?: The corporate mailing address for Ms. Heisz and other Edwards Lifesciences executives is ONE EDWARDS WAY, IRVINE CA, 92614. Edwards Lifesciences can also be reached via phone at (949) 250-2500 and via email at [email protected]. Learn More on Leslie S. Heisz's contact information.
Has Leslie S. Heisz been buying or selling shares of Edwards Lifesciences?: Leslie S. Heisz has not been actively trading shares of Edwards Lifesciences over the course of the past ninety days. Most recently, Heisz Leslie Stone sold 7,056 shares of the business's stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $86.45, for a transaction totalling $609,991.20. Following the completion of the sale, the director now directly owns 26,980 shares of the company's stock, valued at $2,332,421. Learn More on Leslie S. Heisz's trading history.
Who are Edwards Lifesciences' active insiders?: Edwards Lifesciences' insider roster includes Donald Bobo, Jr (VP), Daveen Chopra (VP), Kieran Gallahue (Director), Leslie Heisz (Director), Jean-Luc Lemercier (VP), Martha Marsh (Director), Michael Mussallem (CEO), Robert Sellers (VP), Catherine Szyman (VP), Scott Ullem (CFO), Nicholas Valeriani (Director), Huimin Wang (VP), Larry Wood (VP), and Bernard Zovighian (VP). Learn More on Edwards Lifesciences' active insiders.
Are insiders buying or selling shares of Edwards Lifesciences?: In the last year, insiders at the medical research company sold shares 60 times. They sold a total of 768,312 shares worth more than $62,771,727.15. The most recent insider tranaction occured on April, 8th when VP Jean-Luc M Lemercier sold 14,400 shares worth more than $1,329,408.00. Insiders at Edwards Lifesciences own 1.3% of the company. Learn More about insider trades at Edwards Lifesciences.
Information on this page was last updated on 4/8/2024.

Leslie S. Heisz Insider Trading History at Edwards Lifesciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/8/2024	Sell	7,056	$86.45	$609,991.20	26,980
8/10/2023	Sell	3,303	$78.87	$260,507.61	26,980
2/16/2023	Sell	9,671	$76.82	$742,926.22	27,480
4/23/2021	Sell	6,707	$97.52	$654,066.64	29,272

Leslie S. Heisz Buying and Selling Activity at Edwards Lifesciences

Edwards Lifesciences Company Overview

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Today's Range

Now: $87.73

$86.76

$87.92

50 Day Range

MA: $90.18

$84.87

$95.56

2 Week Range

Now: $87.73

$60.57

$96.12

Volume

2,663,641 shs

Average Volume

3,831,539 shs

Market Capitalization

$52.81 billion

P/E Ratio

38.14

Dividend Yield

N/A

Beta

1.05

The "Smart Money" Is Ready for May 1st Are You?

From Stansberry Research | Ad

Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company.

One Former Wall St. Trader Explains Why…